Diversified Trust
NVCR icon

Diversified Trust’s NovoCure NVCR Stock Holding History

Diversified Trust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$710K Buy
+44,504
New +$743K 0.02% 571
2021
Q1 		– Sell
-1,163
Closed -$201K – 829
2020
Q4 		$201K Buy
+1,163
New +$159K 0.01% 673

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Diversified Trust's NVCR Position: Q3 2026 in Review

Diversified Trust opened a new position in NovoCure (NVCR) in Q3 2026: 44,504 shares worth $710K. The stake represents 0.02% of the portfolio and ranks #571 among its holdings. This is a return to the name: Diversified Trust previously reported a position in NVCR as recently as Q4 2020.

Diversified Trust first reported a position in NVCR in Q4 2020 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Diversified Trust held 44,504 shares of NovoCure worth $710K as of Q3 2026.
  • NovoCure was a new Diversified Trust position in Q3 2026.
  • NovoCure made up 0.02% of Diversified Trust's portfolio in Q3 2026, its #571 holding.
  • Diversified Trust first reported a position in NovoCure in Q4 2020 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.